Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT)
Clinical trial NCT02722941 · COMPLETED
Trial details
- NCT number
- NCT02722941
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-10
- Primary completion
- 2020-06-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.